Table 2.
List of transcripts associated with cell proliferation differentiating endometrial cancer from the control. p < 0.05 and FC > 2 or FC <−2.
| Groups Compared | ID | Gene | p-Value | FC | Expression |
|---|---|---|---|---|---|
| G2 vs. C | 213093_at | PRKCA | 0.0051 | −2.7616084 | decreased |
| 218678_at | NES | 0.0007 | −3.5484042 | decreased | |
| 206404_at | FGF9 | 0.0020 | −3.770779 | decreased | |
| 202555_s_at | MYLK | 0.0001 | −7.969888 | decreased | |
| 209540_at | IGF1 | 0.0001 | −11.902487 | decreased | |
| 208299_at | CACNA1I | 0.0042 | 2.0332716 | increased | |
| 211234_x_at | ESR1 | 0.0036 | 2.0671976 | increased | |
| 221477_s_at | SOD2 | 0.0056 | 3.41224 | increased | |
| 215223_s_at | SOD2 | 0.0079 | 3.9286928 | increased | |
| G3 vs. C | 215498_s_at | MAP2K3 | 0.0000 | 2.0928204 | increased |
ID, number of the probe; FC, fold-change; C, control; G, grade of endometrial cancer.